Shanghai Pioneer Holding Ltd (1345.HK)
HKSE · HKD · Healthcare · Pharmaceutical Retailers
HK$1.91 (-0.52%) as of
Key statistics
- Market cap
- 2.21B
- P/E (TTM)
- 15.92
- EPS (TTM)
- 0.120
- Dividend yield
- 5.83%
- 52-week range
- 1.900 – 2.400
- Beta
- -0.19
- Revenue (TTM)
- 1.24B
- Profit margin
- 9.93%
- Volume
- 26.00k
About Shanghai Pioneer Holding Ltd
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; sale of household appliances; and provision of metal finishing, management consulting, information consulting, and market information services. It sells its products to hospitals, medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Shanghai, China
- Employees
- 448
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.